Kerecis

2101 Wilson Blvd, Suite 900
Arlington
VA
22201
United States

Tel: 703-287-8752

About Kerecis

From the town of Isafjordur in northwest Iceland, Kerecis develops, manufactures, and sells patented fish-skin soft tissue regeneration products that have regulatory approval in the United States, Europe and several other jurisdictions. We provide our customers with innovative digital tools for managing their business that include the use artificial intelligence (AI) to support insurance billing.

We have regional headquarters in the United States, Iceland, and Germany. Our 500 employees worldwide include a U.S. salesforce of more than 200 professionals.

CONNECT

Chester Kitt is a 70-year-old fisherman and motorcycle enthusiast from Marysville, WA. He was at risk of having his foot amputated due to a wound that wouldn’t heal. After numerous attempts to close the wound, however, a solution was finally found with Kerecis fish skin. https://www.kerecis.com/fish-skin-saves-a-fisherman-from-amputation/

48 articles about Kerecis

Kerecis to Acquire Swiss Life-Science Company Phytoceuticals, Gains Approval of Kerecis Omega3 Wound for Reimbursement in Switzerland

2/7/2019

Kerecis, the company pioneering the use of fish skin in tissue regeneration, today received a notice from Swiss healthcare authorities that the company's lead product, Kerecis Omega3 Wound, will be reimbursed in Switzerland.
Kerecis Receives Funding From DoD To Develop Fish Skin Burn Treatment

10/25/2016
Kerecis Wound-Treatment Product With Omega3 Fish Skin Now Eligible For Medicare Reimbursement In 45 States

9/19/2016
FDA Approves Kerecis's Omega3-Rich Fish Skin for Surgical Applications

9/14/2016
Kerecis Fish Skin Wound Treatment Finalist For The Wound Innovation Award

5/12/2016
Kerecis Release: High-Impact Trial Results Of Fish Skin Wound Treatment To Be Presented At SAWC Conference

4/14/2016
Kerecis Omega3 Fish Skin Wound Grafts Recruit Significantly More Cells Than A Leading Amnion Membrane Wound Treatment Brand

9/29/2015
Studies On The Kerecis Fish Skin Graft Show That The Product Recruits Stem Cells And Closes Wounds Significantly Faster Than The Leading Competitive Product

8/18/2015
Medical Fish Skin Company Kerecis And The US Army Office Of Naval Research To Develop New Treatments For Severely Injured Limbs

5/1/2015
Kerecis Establishes U.S. Presence And Names Chris Harte Chief Operating Officer

2/26/2015
Kerecis To Present At NASDAQ OMX

5/27/2014
Kerecis Release: Fish-Skin Medical Company Completes Funding Round

2/24/2014
Kerecis Receives U.S. Patent For Fish-Skin-Based Tissue Regeneration Technology

2/14/2014
The Mermaid Treatment? Fish Skin As Chronic Wound Healing Tech For Diabetics, Kerecis Reveals

11/12/2013
FDA Clears Kerecis's Fish-Skin Technology to Heal Human Wounds

11/7/2013
Kerecis Completes Successful Immunology Study

5/3/2013
Kerecis Completes $1 Million Series A2 Funding

4/26/2013
Kerecis Announces a Distribution Agreement With Medline Industries, Inc. for the MariGen Omega3 Tissue-Regeneration Technology

2/1/2013
Kerecis Follow-Up Study Demonstrates Safety and Efficacy of Omega3 Wound-Healing Treatment

5/21/2012
Kerecis Release: Clinical Trial Demonstrates Safety and Efficacy of Wound-Healing Treatment

10/7/2011